Column Group III Amends Tenaya Therapeutics Stake

TL;DR

**Column Group III, LP just updated their 13D filing on Tenaya Therapeutics on Feb 14, 2024.**

AI Summary

COLUMN GROUP III, LP filed an Amendment No. 2 to its Schedule 13D on February 14, 2024, regarding its beneficial ownership in Tenaya Therapeutics, Inc. This filing updates previous disclosures concerning the Common Stock, $0.0001 par value, of Tenaya Therapeutics. The CUSIP number for these securities is 87990A106.

Why It Matters

This amendment indicates an update to a significant shareholder's position in Tenaya Therapeutics, which could signal changes in their investment strategy or ownership percentage.

Risk Assessment

Risk Level: low — The filing is an amendment to a beneficial ownership report, and without details on the change, the immediate impact or risk is unclear from this snippet alone.

Key Players & Entities

• COLUMN GROUP III, LP (company) — Filer
• Tenaya Therapeutics, Inc. (company) — Subject Company/Issuer
• James Evangelista (person) — Contact for The Column Group
• The Column Group (company) — Associated with Filer
• COLUMN GROUP III GP, LP (company) — Group Member
• COLUMN GROUP III-A, LP (company) — Group Member
• COLUMN GROUP OPPORTUNITY III GP, LP (company) — Group Member
• COLUMN GROUP OPPORTUNITY III, LP (company) — Group Member
• TCG OPPORTUNITY III GP, LLC (company) — Group Member

FAQ

Key Financial Figures

• $0.0001 — INC. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securiti
• $2.5956 — or a weighted-average purchase price of $2.5956 per share and an aggregate purchase pri
• $17,595.57 — hare and an aggregate purchase price of $17,595.57. On February 12, 2024, TCG Opportunit
• $4.50 — low-on offering for a purchase price of $4.50 per share (the February Follow-On Offer
• $9,999,999.00 — ng ) and an aggregate purchase price of $9,999,999.00. Item6. Contracts, Arrangements, Unde

Filing Documents

• d726884dsc13da.htm (SC 13D/A) — 109KB
• 0001193125-24-036263.txt ( ) — 111KB

of the Original Schedule 13D is hereby amended by adding the following as the last paragraphs thereof

Item 3 of the Original Schedule 13D is hereby amended by adding the following as the last paragraphs thereof: On March 10, 2023, TCG Opportunity III LP purchased 6,779 shares of Common Stock for a weighted-average purchase price of $2.5956 per share and an aggregate purchase price of $17,595.57. On February 12, 2024, TCG Opportunity III LP purchased 2,222,222 shares of Common Stock in the Issuers follow-on offering for a purchase price of $4.50 per share (the February Follow-On Offering ) and an aggregate purchase price of $9,999,999.00. Item6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

of the Original Schedule 13D is hereby amended by adding the following language as the last paragraph thereof

Item 6 of the Original Schedule 13D is hereby amended by adding the following language as the last paragraph thereof: In connection with the February Follow-on Offering, each of TCG III LP, TCG III-A LP and TCG Opportunity III LP entered into a lock-up agreement, pursuant to which each such party agreed, subject to certain exceptions, not to sell, transfer or otherwise convey certain of the Issuers securities held by TCG III LP, TCG III-A LP or TCG Opportunity III LP for 60 days following the date of the final prospectus for the February Follow-on Offering. The terms and provisions of such lock-up agreement are described more fully in the prospectus supplement for the February Follow-on Offering, and the above summary is qualified by reference to such description and the full text of the lock-up agreement, a form of which is filed as Exhibit 5 to this Statement and is incorporated herein by reference. Item7. Material to be Filed as Exhibits. Exhibit 5: Form of Lock-Up Agreement for certain directors, officers and other stockholders of the Issuer (included as Exhibit A to the form of Underwriting Agreement filed as Exhibit 1.1 to the Issuers Current Report on Form 8-K as filed with the Commission on February 8, 2024 (SEC File No. 001-40656) and incorporated herein by reference). SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 14, 2024. THE COLUMN GROUP III, LP THE COLUMN GROUP III GP, LP By: The Column Group III GP, LP By: /s/ James Evangelista, Attorney in Fact By: /s/ James Evangelista, Attorney in Fact Name: James Evangelista Name: James Evangelista Title: Attorney in Fact Title: Attorney in Fact THE COLUMN GROUP III-A, LP THE COLUMN GROUP OPPORTUNITY III, LP By: The Column Group III GP, LP By: The Column Group Opportunity III GP, LP By: TCG Opportunity III GP, LLC By